SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 111.64   -0.27 (-0.24%) Volume: 351.01k 4:00 PM EDT Jul 2, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities111/17/2017
4Statement of changes in beneficial ownership of securities111/17/2017
4Statement of changes in beneficial ownership of securities111/17/2017
8-KCurrent report pursuant to Section 13 or 15(d)11811/14/2017
CT ORDERConfidential treatment order111/13/2017
8-KCurrent report pursuant to Section 13 or 15(d)311/13/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)4211/09/2017
8-KCurrent report pursuant to Section 13 or 15(d)1311/09/2017
10-Q/A[Amend] Quarterly report [Sections 13 or 15(d)]4411/02/2017
4Statement of changes in beneficial ownership of securities110/17/2017
8-KCurrent report pursuant to Section 13 or 15(d)310/10/2017
8-KCurrent report pursuant to Section 13 or 15(d)10010/04/2017
4Statement of changes in beneficial ownership of securities109/06/2017
4Statement of changes in beneficial ownership of securities108/25/2017
3Initial statement of beneficial ownership of securities108/22/2017
101112131415161718192021222324